Ryman Healthcare COVID-19 update Victoria

Ryman Healthcare COVID-19 update Victoria August 3, 2020


Ryman Healthcare wishes to update shareholders on the impact of the Victorian
Government’s latest restrictions to prevent the spread of COVID-19.
Ryman’s two operational villages, Weary Dunlop and Nellie Melba, have been in lockdown
for the past four weeks with visiting restricted and full pandemic infection control measures
in place.
The village teams have been delivering groceries and essential supplies to residents and
helping to ensure care residents can keep in touch over Zoom and by phone.
The Victorian Government yesterday afternoon announced additional Level 4 lockdown
restrictions.
These restrictions mean work at our Nellie Melba, Burwood East and Aberfeldie
construction sites will be significantly reduced over the next six weeks.
The Government will provide additional guidance over the next few days, and the
restrictions will come into force at midnight on Friday, August 7.
Construction on our Highton and Ocean Grove villages, which are outside Metropolitan
Melbourne and are not subject to the Level 4 lockdown restrictions, will be able to continue
in the meantime.
New residents can move into Weary Dunlop and Nellie Melba within the health guidelines.
Sales appointments in person are restricted but can continue over Zoom, and our sales
teams are working to keep all our prospective buyers up to date.
At this early stage of the lockdown it is hard to predict what impact it may have on our
previously communicated target of delivering 900 beds and units in the 2021 financial year.
As previously communicated our annual shareholders’ meeting will be held in Christchurch
on August 13.

About Ryman: Ryman Healthcare was founded in Christchurch in 1984 and owns and
operates 36 retirement villages in New Zealand and Victoria. Ryman villages are home to
more than 11,600 residents, and the company employs more than 6,000 staff.
Contacts: For media information or images contact David King, Corporate Affairs
Manager, on 021 499 602 (+64 21 499 602) or email david.king@rymanhealthcare.com
For investor relations information contact Michelle Perkins, Investor Relations Manager, on
027 222 9684 (+64 27 222 9684) or email michelle.perkins@rymanhealthcare.com